Requests for Medical Termination of Pregnancy for Psychological or Social Maternal Reasons

NCT ID: NCT05499325

Last Updated: 2022-08-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-08-17

Study Completion Date

2022-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

When the request for termination of pregnancy is made at a term of less than sixteen weeks of amenorrhea, the patients have complete decision-making autonomy. This is called voluntary termination of pregnancy. On the other hand, when they are made after this term, their requests must be subject to a multidisciplinary assessment. This is called medical termination of pregnancy for maternal indication. Schematically, there are two categories of indications: "organic" (progressive cancer, severe heart disease, etc.) and "psycho-social". In the latter case, and although the recommendations of the CNGOF recommend a formalization of these requests in the centers where the patients are received, strong disparities are observed in practice. In addition, there are few epidemiological and clinical data concerning these medical terminations of pregnancy with a psychological or social maternal indication in the literature.

The objective of this work is to describe the demographic characteristics of patients who have made a request for termination of pregnancy after the legal deadline for psychological or social maternal reasons, and to specify the care pathways of these patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Retrospective cohort (from 01/01/2016 to 02/28/2022) single-centre involving data from patients followed at the Maison des Femmes, and eligible for the study.

The demographic and care pathway variables will be the subject of a descriptive statistical analysis.

Expected results: improvement of knowledge relating to patients who consulted for termination of pregnancy after sixteen weeks of amenorrhea and their care pathway.

Outlook:

* Improving the knowledge of health professionals and therefore of care pathways, with a view to a more homogeneous use of legal systems.
* Improvement and simplification of care pathways.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy Related

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Minor or adult patients who have been seen at the Maison des Femmes in the context of a request for termination of pregnancy for psychological and/or social maternal reasons, including patients subject to a legal protection measure (guardianship , curators) during the consultation
* Consultation between 01/01/2016 and 02/28/2022

Exclusion Criteria

* Refusal of inclusion in a study explained in the medical file (patient or guardian)
* Objection to the use of data or refusal to participate (patient or guardian)
Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier de Saint-Denis

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital DELAFONTAINE

Saint-Denis, Île-de-France Region, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Anne BEDU, JD

Role: CONTACT

01.42.35.61.28

Tiphaine DE FOUCHER DE CAREIL, MD

Role: CONTACT

01.42.35.61.28

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Stéphanie COSSEC

Role: primary

01 42 35 61 40 ext. 6962

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHSD_0028_MATER

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Optimal Treatment of Miscarriage
NCT01033903 COMPLETED NA